BioCentury | Oct 22, 2007
Company News

Grant Life Sciences deal

...and 18 from Russian scientists Peter Sveshnikov and Vsevolod Kiselev. Further terms were not disclosed. Grant Life Sciences Inc....
BioCentury | Jun 18, 2007
Company News

Alphagenics Diaco Biotechnologies s.r.l., Grant Life Sciences deal

...is developing a serum-based, immunological HPV blood test. Alphagenics Diaco Biotechnologies s.r.l. , Trieste, Italy Grant Life Sciences Inc....
BioCentury | Apr 2, 2007
Company News

Grant management update

Grant Life Sciences Inc. (GLIF), Murray, Utah Business: Diagnostic Hired: Steven Passey as CFO, formerly a CFO partner at Tatum LLC; he replaces Donald Rutherford, who retired WIR Staff Diagnostic...
BioCentury | Mar 16, 2007
Company News

Life Science in-licenses Kyowa's KW-2871

Kyowa Hakko Kogyo (Tokyo:4151) granted Life Science Pharmaceuticals (Greenwich, Conn.) exclusive worldwide rights to develop and market KW-2871 to treat malignant melanoma. Life Science plans to start a Phase II trial of the chimeric MAb...
BioCentury | Jun 5, 2006
Company News

Life Science Pharmaceuticals, Ludwig Institute for Cancer Research deal

The institute granted Life Science exclusive worldwide rights to develop and commercialize three MAbs for cancer and autoimmune diseases. The antibodies target epidermal growth factor receptor (EGFR) , fibroblast activating protein, and an undisclosed epitope involved...
BioCentury | Oct 10, 2005
Company News

Grant management update

Grant Life Sciences Inc. (GLIF), Murray, Utah Business: Supply/Service Resigned: Eric Wilkinson as co-CEO and a director Hired: Hun-Chi Lin as president, CSO and a director, formerly president of XepMed Inc. WIR Staff...
BioCentury | Aug 15, 2005
Company News

Grant management update

Grant Life Sciences Inc. (GLIF), Murray, Utah Business: Supply/Service, Diagnostic Retired: Stan Yakatan as CEO; directors Eric Wilkinson and Kevin Crow will serve as interim co-CEOs WIR Staff Diagnostic...
BioCentury | Aug 11, 2005
Company News

Yakatan leaves Grant Life Sciences

GLIF said Stan Yakatan retired as CEO but will remain chairman. Company directors Eric Wilkinson and Kevin Crow will serve as interim co-CEOs. GLIF is developing protein-based screening tests for cervical cancer. BC Staff...
BioCentury | May 16, 2005
Clinical News

Immunodiagnostic test update

...the immunodiagnostic test. Patient enrollment is expected to be complete within 6 to 8 months. Grant Life Sciences Inc....
BioCentury | Dec 6, 2004
Company News

Grant management update

Grant Life Sciences Inc. (GLIF), Salt Lake City, Utah Business: Diagnostic, Cancer Hired: David Bolick as CMO, formerly founder, medical director and senior pathologist at Reference Pathology Services, now part of Ameripath Inc. WIR Staff...
Items per page:
1 - 10 of 11
BioCentury | Oct 22, 2007
Company News

Grant Life Sciences deal

...and 18 from Russian scientists Peter Sveshnikov and Vsevolod Kiselev. Further terms were not disclosed. Grant Life Sciences Inc....
BioCentury | Jun 18, 2007
Company News

Alphagenics Diaco Biotechnologies s.r.l., Grant Life Sciences deal

...is developing a serum-based, immunological HPV blood test. Alphagenics Diaco Biotechnologies s.r.l. , Trieste, Italy Grant Life Sciences Inc....
BioCentury | Apr 2, 2007
Company News

Grant management update

Grant Life Sciences Inc. (GLIF), Murray, Utah Business: Diagnostic Hired: Steven Passey as CFO, formerly a CFO partner at Tatum LLC; he replaces Donald Rutherford, who retired WIR Staff Diagnostic...
BioCentury | Mar 16, 2007
Company News

Life Science in-licenses Kyowa's KW-2871

Kyowa Hakko Kogyo (Tokyo:4151) granted Life Science Pharmaceuticals (Greenwich, Conn.) exclusive worldwide rights to develop and market KW-2871 to treat malignant melanoma. Life Science plans to start a Phase II trial of the chimeric MAb...
BioCentury | Jun 5, 2006
Company News

Life Science Pharmaceuticals, Ludwig Institute for Cancer Research deal

The institute granted Life Science exclusive worldwide rights to develop and commercialize three MAbs for cancer and autoimmune diseases. The antibodies target epidermal growth factor receptor (EGFR) , fibroblast activating protein, and an undisclosed epitope involved...
BioCentury | Oct 10, 2005
Company News

Grant management update

Grant Life Sciences Inc. (GLIF), Murray, Utah Business: Supply/Service Resigned: Eric Wilkinson as co-CEO and a director Hired: Hun-Chi Lin as president, CSO and a director, formerly president of XepMed Inc. WIR Staff...
BioCentury | Aug 15, 2005
Company News

Grant management update

Grant Life Sciences Inc. (GLIF), Murray, Utah Business: Supply/Service, Diagnostic Retired: Stan Yakatan as CEO; directors Eric Wilkinson and Kevin Crow will serve as interim co-CEOs WIR Staff Diagnostic...
BioCentury | Aug 11, 2005
Company News

Yakatan leaves Grant Life Sciences

GLIF said Stan Yakatan retired as CEO but will remain chairman. Company directors Eric Wilkinson and Kevin Crow will serve as interim co-CEOs. GLIF is developing protein-based screening tests for cervical cancer. BC Staff...
BioCentury | May 16, 2005
Clinical News

Immunodiagnostic test update

...the immunodiagnostic test. Patient enrollment is expected to be complete within 6 to 8 months. Grant Life Sciences Inc....
BioCentury | Dec 6, 2004
Company News

Grant management update

Grant Life Sciences Inc. (GLIF), Salt Lake City, Utah Business: Diagnostic, Cancer Hired: David Bolick as CMO, formerly founder, medical director and senior pathologist at Reference Pathology Services, now part of Ameripath Inc. WIR Staff...
Items per page:
1 - 10 of 11